Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT – Prophylaxis of ThromboEmbolism in Critical Care Trial
2009-012387-13Phase 4Completed
- Sponsor
- McMaster University
- Start
- Mar 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in venous thromboembolism (VTE) comparing Dalteparin arm with Unfractionated heparin arm (2 arms). Primary endpoint: Proximal deep vein thrombosis. Started Mar 2010; status: completed.
02
Drugs
dalteparinheparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2009-012387-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012387-13.